Clinical trials
Completed Essential Hypertension trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
77 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 7 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 4 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 10 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boryung Pharmaceutical Co., Ltd | 25 |
| Chong Kun Dang Pharmaceutical | 11 |
| Addpharma Inc. | 6 |
| Novartis Pharmaceuticals | 5 |
| Celltrion Pharm, Inc. | 3 |
| Handok Inc. | 3 |
| Celltrion | 2 |
| Daewoong Pharmaceutical Co. LTD. | 2 |
| HK inno.N Corporation | 2 |
| Shin Poong Pharmaceutical Co. Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 77 |
| Hypertension | 19 |
| Diabetes Mellitus, Type 2 | 3 |
| Dyslipidemias | 3 |
| Hyperlipidemias | 3 |
| Cardiovascular Diseases | 1 |
| Diabetic Nephropathies | 1 |
| Heart Failure | 1 |
| Hypercholesterolemia | 1 |
| Proteinuria | 1 |
Trials
Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.